Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis

Alessandro Alimonti, Giovanni Ristori, Franco Giubilei, Maria Antonia Stazi, Anna Pino, Andrea Visconti, Sonia Brescianini, Micaela Sepe Monti, Giovanni Forte, Paolo Stanzione, Beatrice Bocca, Giuseppe Bomboi, Cristina D'Ippolito, Viviana Annibali, Marco Salvetti, Giuseppe Sancesario

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The role of some chemical elements in neurodegeneration was suggested by various authors. To obtain a profile of chemical elements and oxidative status in complex neurological diseases, an unbiased "omics" approach, i.e., quantification of 26 elements and oxidative stress parameters (serum oxidative status (SOS) and serum anti-oxidant capacity (SAC)), combined with multivariate statistical procedures (forward discriminant analysis, FDA) to analyse the vast amount of data, was applied to four groups of subjects (53 patients with Alzheimer's disease (AD), 71 with Parkinson disease (PD), 60 with multiple sclerosis (MS) and 124 healthy individuals). Descriptive statistics revealed numerous differences between each disease and healthy status. A concordant imbalance (reduction in Fe, Zn and SAC, and increase in SOS) was shared by AD, PD and MS. The FDA yielded three significant discriminant functions based on age, SOS, Ca, Fe, Si, Sn, V, Zn and Zr, and identified disease-specific profiles of element imbalances, thus showing the appropriateness of the "omics" approach. It may help assess the contribution of chemical elements and oxidative stress to disease causation and may provide complex predictors of disease evolution or treatment response.

Original languageEnglish
Pages (from-to)450-456
Number of pages7
JournalNeuroToxicology
Volume28
Issue number3
DOIs
Publication statusPublished - May 2007

Fingerprint

Chemical elements
Multiple Sclerosis
Parkinson Disease
Alzheimer Disease
Serum
Discriminant Analysis
Oxidants
Oxidative Stress
Oxidative stress
Discriminant analysis
Causality
Statistics
Therapeutics

Keywords

  • Alzheimer's disease
  • Chemical elements
  • Forward discriminant analysis
  • Multiple sclerosis
  • Parkinson disease
  • Serum oxidative status

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Neuroscience(all)
  • Toxicology

Cite this

Alimonti, A., Ristori, G., Giubilei, F., Stazi, M. A., Pino, A., Visconti, A., ... Sancesario, G. (2007). Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. NeuroToxicology, 28(3), 450-456. https://doi.org/10.1016/j.neuro.2006.12.001

Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. / Alimonti, Alessandro; Ristori, Giovanni; Giubilei, Franco; Stazi, Maria Antonia; Pino, Anna; Visconti, Andrea; Brescianini, Sonia; Monti, Micaela Sepe; Forte, Giovanni; Stanzione, Paolo; Bocca, Beatrice; Bomboi, Giuseppe; D'Ippolito, Cristina; Annibali, Viviana; Salvetti, Marco; Sancesario, Giuseppe.

In: NeuroToxicology, Vol. 28, No. 3, 05.2007, p. 450-456.

Research output: Contribution to journalArticle

Alimonti, A, Ristori, G, Giubilei, F, Stazi, MA, Pino, A, Visconti, A, Brescianini, S, Monti, MS, Forte, G, Stanzione, P, Bocca, B, Bomboi, G, D'Ippolito, C, Annibali, V, Salvetti, M & Sancesario, G 2007, 'Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis', NeuroToxicology, vol. 28, no. 3, pp. 450-456. https://doi.org/10.1016/j.neuro.2006.12.001
Alimonti, Alessandro ; Ristori, Giovanni ; Giubilei, Franco ; Stazi, Maria Antonia ; Pino, Anna ; Visconti, Andrea ; Brescianini, Sonia ; Monti, Micaela Sepe ; Forte, Giovanni ; Stanzione, Paolo ; Bocca, Beatrice ; Bomboi, Giuseppe ; D'Ippolito, Cristina ; Annibali, Viviana ; Salvetti, Marco ; Sancesario, Giuseppe. / Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. In: NeuroToxicology. 2007 ; Vol. 28, No. 3. pp. 450-456.
@article{e926b3ecbde14411aec977127959269f,
title = "Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis",
abstract = "The role of some chemical elements in neurodegeneration was suggested by various authors. To obtain a profile of chemical elements and oxidative status in complex neurological diseases, an unbiased {"}omics{"} approach, i.e., quantification of 26 elements and oxidative stress parameters (serum oxidative status (SOS) and serum anti-oxidant capacity (SAC)), combined with multivariate statistical procedures (forward discriminant analysis, FDA) to analyse the vast amount of data, was applied to four groups of subjects (53 patients with Alzheimer's disease (AD), 71 with Parkinson disease (PD), 60 with multiple sclerosis (MS) and 124 healthy individuals). Descriptive statistics revealed numerous differences between each disease and healthy status. A concordant imbalance (reduction in Fe, Zn and SAC, and increase in SOS) was shared by AD, PD and MS. The FDA yielded three significant discriminant functions based on age, SOS, Ca, Fe, Si, Sn, V, Zn and Zr, and identified disease-specific profiles of element imbalances, thus showing the appropriateness of the {"}omics{"} approach. It may help assess the contribution of chemical elements and oxidative stress to disease causation and may provide complex predictors of disease evolution or treatment response.",
keywords = "Alzheimer's disease, Chemical elements, Forward discriminant analysis, Multiple sclerosis, Parkinson disease, Serum oxidative status",
author = "Alessandro Alimonti and Giovanni Ristori and Franco Giubilei and Stazi, {Maria Antonia} and Anna Pino and Andrea Visconti and Sonia Brescianini and Monti, {Micaela Sepe} and Giovanni Forte and Paolo Stanzione and Beatrice Bocca and Giuseppe Bomboi and Cristina D'Ippolito and Viviana Annibali and Marco Salvetti and Giuseppe Sancesario",
year = "2007",
month = "5",
doi = "10.1016/j.neuro.2006.12.001",
language = "English",
volume = "28",
pages = "450--456",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis

AU - Alimonti, Alessandro

AU - Ristori, Giovanni

AU - Giubilei, Franco

AU - Stazi, Maria Antonia

AU - Pino, Anna

AU - Visconti, Andrea

AU - Brescianini, Sonia

AU - Monti, Micaela Sepe

AU - Forte, Giovanni

AU - Stanzione, Paolo

AU - Bocca, Beatrice

AU - Bomboi, Giuseppe

AU - D'Ippolito, Cristina

AU - Annibali, Viviana

AU - Salvetti, Marco

AU - Sancesario, Giuseppe

PY - 2007/5

Y1 - 2007/5

N2 - The role of some chemical elements in neurodegeneration was suggested by various authors. To obtain a profile of chemical elements and oxidative status in complex neurological diseases, an unbiased "omics" approach, i.e., quantification of 26 elements and oxidative stress parameters (serum oxidative status (SOS) and serum anti-oxidant capacity (SAC)), combined with multivariate statistical procedures (forward discriminant analysis, FDA) to analyse the vast amount of data, was applied to four groups of subjects (53 patients with Alzheimer's disease (AD), 71 with Parkinson disease (PD), 60 with multiple sclerosis (MS) and 124 healthy individuals). Descriptive statistics revealed numerous differences between each disease and healthy status. A concordant imbalance (reduction in Fe, Zn and SAC, and increase in SOS) was shared by AD, PD and MS. The FDA yielded three significant discriminant functions based on age, SOS, Ca, Fe, Si, Sn, V, Zn and Zr, and identified disease-specific profiles of element imbalances, thus showing the appropriateness of the "omics" approach. It may help assess the contribution of chemical elements and oxidative stress to disease causation and may provide complex predictors of disease evolution or treatment response.

AB - The role of some chemical elements in neurodegeneration was suggested by various authors. To obtain a profile of chemical elements and oxidative status in complex neurological diseases, an unbiased "omics" approach, i.e., quantification of 26 elements and oxidative stress parameters (serum oxidative status (SOS) and serum anti-oxidant capacity (SAC)), combined with multivariate statistical procedures (forward discriminant analysis, FDA) to analyse the vast amount of data, was applied to four groups of subjects (53 patients with Alzheimer's disease (AD), 71 with Parkinson disease (PD), 60 with multiple sclerosis (MS) and 124 healthy individuals). Descriptive statistics revealed numerous differences between each disease and healthy status. A concordant imbalance (reduction in Fe, Zn and SAC, and increase in SOS) was shared by AD, PD and MS. The FDA yielded three significant discriminant functions based on age, SOS, Ca, Fe, Si, Sn, V, Zn and Zr, and identified disease-specific profiles of element imbalances, thus showing the appropriateness of the "omics" approach. It may help assess the contribution of chemical elements and oxidative stress to disease causation and may provide complex predictors of disease evolution or treatment response.

KW - Alzheimer's disease

KW - Chemical elements

KW - Forward discriminant analysis

KW - Multiple sclerosis

KW - Parkinson disease

KW - Serum oxidative status

UR - http://www.scopus.com/inward/record.url?scp=34249669195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249669195&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2006.12.001

DO - 10.1016/j.neuro.2006.12.001

M3 - Article

C2 - 17267042

AN - SCOPUS:34249669195

VL - 28

SP - 450

EP - 456

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

IS - 3

ER -